Advertisement

Author: PWeekly

Addition of Ibrutinib to Chemoimmunotherapy in CLL

The combination of fludarabine, cyclophosphamide, and rituximab (FCR) is the only regimen other than allotransplantation shown in studies to result in a significant chance of functional cure in very long-term follow-up for...

Read More

For latest news and updates
Email-id is invalid